ResearcherQilu Hospital of Shandong UniversityNo recent work listed

Feng Li

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5100984562. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer. Co-author DOI 10.1080/21691401.2017.1315429 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jianwei Xu · 1 shared paper, 2018 · strength 0.10
- Paper MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer. DOI 10.1080/21691401.2017.1315429 ↗
Lei Wang · 1 shared paper, 2018 · strength 0.10
- Paper MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer. DOI 10.1080/21691401.2017.1315429 ↗
Sanyuan Hu · 1 shared paper, 2018 · strength 0.10
- Paper MicroRNA-221-3p is up-regulated and serves as a potential biomarker in pancreatic cancer. DOI 10.1080/21691401.2017.1315429 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.